Literature DB >> 11404466

Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice.

S Millecamps1, D Nicolle, I Ceballos-Picot, J Mallet, M Barkats.   

Abstract

Using adenoviruses encoding reporter genes as retrograde tracers, we assessed the capacity of motoneurons to take up and retrogradely transport adenoviral particles injected into the muscles of transgenic mice expressing the G93A human superoxide dismutase mutation, a model of amyotrophic lateral sclerosis. Surprisingly, transgene expression in the motoneurons was significantly higher in symptomatic mice than in control or presymptomatic mice. Using botulinum toxin to induce nerve sprouting at neuromuscular junctions, we showed that the unexpectedly high level of motoneurons retrograde transduction results, at least in part, from newly acquired uptake properties of the sprouts. These findings demonstrate the remarkable uptake properties of amyotrophic lateral sclerosis motoneurons in response to denervation and the rationale of using intramuscular injections of adenoviruses to overexpress therapeutic proteins in motor neuron diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404466      PMCID: PMC34711          DOI: 10.1073/pnas.131031098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Second-generation adenovirus vectors.

Authors:  Q Wang; M H Finer
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

2.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

3.  GAP-43 immunoreactivity is detected in the nerve terminals of patients with amyotrophic lateral sclerosis.

Authors:  A Ueki; Y Namba; M Otsuka; M Okuno; M Nishimura; M Oda; K Ikeda
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Dephosphorylation of neuromodulin by calcineurin.

Authors:  Y C Liu; D R Storm
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

6.  Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.

Authors:  O Corti; A Sánchez-Capelo; P Colin; N Hanoun; M Hamon; J Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

7.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

9.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.

Authors:  B Zhang; P Tu; F Abtahian; J Q Trojanowski; V M Lee
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

View more
  8 in total

1.  Cytoplasmic dynein mediates adenovirus binding to microtubules.

Authors:  Samir A Kelkar; K Kevin Pfister; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.

Authors:  Mai K ElMallah; Darin J Falk; Michael A Lane; Thomas J Conlon; Kun-Ze Lee; Nadeem I Shafi; Paul J Reier; Barry J Byrne; David D Fuller
Journal:  Hum Gene Ther Methods       Date:  2012-04       Impact factor: 2.396

3.  Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.

Authors:  S E Smittkamp; J W Brown; J A Stanford
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

4.  Hypoglossal neuropathology and respiratory activity in pompe mice.

Authors:  Kun-Ze Lee; Kai Qiu; Milapjit S Sandhu; Mai K Elmallah; Darin J Falk; Michael A Lane; Paul J Reier; Barry J Byrne; David D Fuller
Journal:  Front Physiol       Date:  2011-06-30       Impact factor: 4.566

Review 5.  Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.

Authors:  Jik Nijssen; Laura H Comley; Eva Hedlund
Journal:  Acta Neuropathol       Date:  2017-04-13       Impact factor: 17.088

6.  Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.

Authors:  Ilary Allodi; Laura Comley; Susanne Nichterwitz; Monica Nizzardo; Chiara Simone; Julio Aguila Benitez; Ming Cao; Stefania Corti; Eva Hedlund
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

7.  Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.

Authors:  Laura H Comley; Jik Nijssen; Johanna Frost-Nylen; Eva Hedlund
Journal:  J Comp Neurol       Date:  2015-11-23       Impact factor: 3.215

8.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.